Commitment to Quality
Veliter Biomedical Technology provides one-stop oligo CDMO Solutions from preclinincal to commercial
Products & Services
Synthesis of various types of oligonucleotide molecules such as siRNA, ASO, PMO, and Aptamer
Synthesis of oligonucleotide conjugates such as peptide-coupled oligonucleotide and antibody-coupled oligonucleotide
Guangdong Veliter Biomedical Technology Co.,Ltd was founded in July 2019 led by experts with specialized knowledge unique to oligonucleotide process development and manufacturing, tens of years of experience in pre-clinical and clinical development of innovative oligo drug products, come from globally recognized pharmaceutical enterprises and CDMO firms, specializes in phase appropriate analytical method development/validation, process development/validation, scale-up, non-GMP and GMP manufacturing, formulation, and CMC/regulatory solutions/services.
Our product portfolio encompasses Deoxyribonucleic acid (DNA), Ribonucleic acid (RNA), Phosphorodiamidate morpholino oligonucleotides (PMO), and Peptide-conjugated phosphorodiamidate morpholino oligonucleotides (PPMO) which diversify into ASO, siRNA, miRNA, Aptamer, circleRNA, CpG ODN, sgRNA, among others.
Positive oligo program experience, from end to end
Focusing on your needs and building long-term partnerships, your own Veliter’s project manager will be flexible and responsive. This is Veliter’s approach to make your oligonucleotide program move smoothly through pre-clinical to commercial.
